FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, particularly to a method of increasing the levels of at least two of PDE10a, DARPP-32, DRD1 and DRD2 in median spinule neurons (MSN) of a human subject or a mouse subject. Method involves introducing a genetic repressor into a stabile body containing a polynucleotide encoding a zinc finger-based DNA-binding protein (ZFP) containing 3 to 6 "zinc finger" domains. Also disclosed is a method of treating Huntington's disease in a human subject or mouse subject, involving increasing levels of at least two of PDE10a, DARPP-32, DRD1 and DRD2 in median spinule neurons (MSN) using said method.
EFFECT: invention enables effective treatment of Huntington's disease in a human subject or a mouse subject.
9 cl, 18 dwg, 4 tbl, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR HUNTINGTON DISEASE TREATMENT | 2013 |
|
RU2639277C2 |
| METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE | 2015 |
|
RU2691102C2 |
| TAU MODULATORS AND METHODS AND COMPOSITIONS FOR THEIR DELIVERY | 2017 |
|
RU2789459C2 |
| ENGINEERED ZINC FINGER PROTEINS TARGETING PLANT GENES INVOLVED IN FATTY ACID BIOSYNTHESIS | 2010 |
|
RU2712833C2 |
| CELL TARGETING MEDIATED BY CHIMERIC ANTIGEN RECEPTOR | 2018 |
|
RU2783316C2 |
| CONSTRUCTED PROTEINS WITH ZINC FINGERS DIRECTED TOWARDS GENES OF PLANTS INVOLVED IN BIOSYNTHESIS OF FATTY ACIDS | 2010 |
|
RU2568056C2 |
| TARGETED MODIFICATION OF MALATE DEHYDROGENASE | 2013 |
|
RU2658437C2 |
| FAD2 PERFORMANCE LOCI AND CORRESPONDING TARGET SITE SPECIFIC BINDING PROTEINS CAPABLE OF INDUCING TARGETED BREAKS | 2013 |
|
RU2656158C2 |
| FAD3 PERFORMANCE LOCI AND CORRESPONDING TARGET SITE SPECIFIC BINDING PROTEINS CAPABLE OF INDUCING TARGETED BREAKS | 2013 |
|
RU2665811C2 |
| METHODS AND COMPOSITIONS FOR EMBEDDING AN EXOGENOUS SEQUENCE INTO A PLANT GENOME | 2014 |
|
RU2723130C2 |
